LGM Pharma Announces New CEO

By Akia Thorpe -

April 10, 2018

LGM Pharma, an Erlanger, Kentucky-headquartered active pharmaceutical ingredient manufacturer, has announced that Dr. Prasad S. Raje, PhD has been named Chief Executive Officer (CEO).

In this capacity, Dr. Raje will be heading up all company management activities as well as implementing various growth strategies for the company and will be working out of LGM’s business offices based in Boca Raton, Florida. LGM co-founders Gideon Schurder, Commercial Director, and Mendy Schurder, Chief Operating Officer, will continue in their roles, working closely with Dr. Raje to execute the growth strategy of the company.

Dr. Raje brings experience and business knowledge in the pharmaceutical industry. Prior to joining LGM Pharma, Dr. Raje was President and CEO at Nanotherapeutics, an Alachua, Florida-headquartered biopharmaceutical company, as the company transformed from product development to a biologics-based contract development and manufacturing organization. Prior to that, Dr. Raje led the Life Sciences Division of EAG Laboratories, a global contract research organization specializing in analytical and toxicology services. Dr. Raje created the Life Sciences Division, overseeing four global sites and helping to drive growth, through both organic and acquisition initiatives. Dr. Raje has previously held leadership roles at Cambridge Major Laboratories, Smithers Pharma Services, Albany Molecular Research (AMRI), and Abbott Labs.

Source: LGM Pharma